Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-18,050
Closed -$3.84M – 79
2021
Q3
$3.84M Hold
18,050
– – 1.23% 37
2021
Q2
$4.4M Hold
18,050
– – 1.58% 27
2021
Q1
$4.49M Hold
18,050
– – 1.66% 25
2020
Q4
$4.15M Hold
18,050
– – 1.63% 24
2020
Q3
$4.59M Hold
18,050
– – 1.88% 15
2020
Q2
$4.26M Buy
18,050
+1,050
+6% +$240K 1.71% 14
2020
Q1
$3.45M Hold
17,000
– – 1.87% 10
2019
Q4
$4.1M Hold
17,000
– – 1.4% 18
2019
Q3
$3.29M Hold
17,000
– – 1.4% 17
2019
Q2
$3.13M Buy
17,000
+2,550
+18% +$457K 1.36% 21
2019
Q1
$2.74M Hold
14,450
– – 1.17% 32
2018
Q4
$2.81M Hold
14,450
– – 1.35% 14
2018
Q3
$3M Hold
14,450
– – 1.34% 16
2018
Q2
$2.67M Hold
14,450
– – 1.27% 29
2018
Q1
$2.46M Hold
14,450
– – 1.15% 38
2017
Q4
$2.51M Buy
14,450
+950
+7% +$168K 1% 44
2017
Q3
$2.52M Hold
13,500
– – 1.33% 24
2017
Q2
$2.32M Hold
13,500
– – 1.23% 29
2017
Q1
$2.22M Hold
13,500
– – 1.16% 32
2016
Q4
$1.97M Buy
13,500
+1,400
+12% +$211K 0.93% 37
2016
Q3
$2.02M Hold
12,100
– – 1.24% 15
2016
Q2
$1.84M Hold
12,100
– – 1.04% 23
2016
Q1
$1.81M Hold
12,100
– – 0.94% 29
2015
Q4
$1.96M Hold
12,100
– – 1.17% 20
2015
Q3
$1.67M Hold
12,100
– – 1.08% 32
2015
Q2
$1.86M Hold
12,100
– – 1% 37
2015
Q1
$1.93M Hold
12,100
– – 0.96% 37
2014
Q4
$1.93M Hold
12,100
– – 1% 32
2014
Q3
$1.7M Hold
12,100
– – 0.94% 41
2014
Q2
$1.43M Hold
12,100
– – 0.92% 57
2014
Q1
$1.49M Hold
12,100
– – 0.69% 73
2013
Q4
$1.38M Hold
12,100
– – 0.65% 81
2013
Q3
$1.35M Hold
12,100
– – 0.87% 39
2013
Q2
$1.19M Hold
12,100
– – 0.8% 49

Other funds holding AMGN

Winmill & Co's AMGN Position: Q4 2021 in Review

Winmill & Co sold out of Amgen (AMGN) in Q4 2021, closing a stake of 18,050 shares — an estimated $3.84M sold.

Winmill & Co first reported a position in AMGN in Q2 2013 and held it in 34 quarters. The position peaked at $4.59M in Q3 2020. 2,290 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Winmill & Co reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Winmill & Co sold 18,050 Amgen shares in Q4 2021, an estimated $3.84M.
  • Winmill & Co first reported a position in Amgen in Q2 2013 and held it in 34 quarters.
  • Winmill & Co's Amgen position peaked at $4.59M in Q3 2020.
  • 2,290 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Winmill & Co's 13F filing for Q4 2021, filed 11 Feb 2022.